Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
Open Access
- 14 February 2020
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 7 (3), 307-317
- https://doi.org/10.1002/acn3.50990
Abstract
Objective To investigate the oxidized albumin ratio, which is the redox ratio of human nonmercaptalbumin (HNA) to serum albumin (%HNA), as a biomarker in idiopathic Parkinson’s disease (iPD) and related neurodegenerative disorders. Methods This prospective study enrolled 216 iPD patients, 15 patients with autosomal recessive familial PD due to parkin mutations (PARK2), 30 multiple system atrophy (MSA) patients, 32 progressive nuclear palsy (PSP) patients, and 143 healthy controls. HNA was analyzed using modified high‐performance liquid chromatography and was evaluated alongside other parameters. Results iPD and PARK2 patients had a higher %HNA than controls (iPD vs. controls: odds ratio (OR) 1.325, P < 0.001; PARK2 vs. controls: OR 1.712, P < 0.001). Even iPD patients at an early Hoehn & Yahr stage (I and II) showed a higher %HNA than controls. iPD patients had a higher %HNA than MSA and PSP patients (iPD vs. MSA: OR 1.249, P < 0.001, iPD vs. PSP: OR 1.288, P < 0.05). When discriminating iPD patients from controls, %HNA corrected by age achieved an AUC of 0.750; when discriminating iPD patients from MSA and PSP patients, an AUC of 0.747 was achieved. Furthermore, uric acid, an antioxidant compound, was decreased in iPD patients, similar to the change in %HNA. Interpretation %HNA was significantly increased in iPD and PARK2 patients compared with controls, regardless of disease course and severity. Oxidative stress might be increased from the early stages of iPD and PARK2 and play an important role in their pathomechanisms.Keywords
This publication has 42 references indexed in Scilit:
- Human serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studiesFree Radical Research, 2013
- The Risk of Parkinson Disease Associated with Urate in a Community-Based Cohort of Older AdultsNeuroepidemiology, 2011
- PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagyFEBS Letters, 2010
- Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s diseaseJournal of Neurochemistry, 2009
- Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) StudyAmerican Journal of Epidemiology, 2009
- Parkin is recruited selectively to impaired mitochondria and promotes their autophagyThe Journal of cell biology, 2008
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- The antioxidant properties of serum albuminFEBS Letters, 2008
- Environmental Factors in Parkinson’s DiseaseNeuroToxicology, 2002
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences of the United States of America, 1981